Will cilostazol improve care for patients with intermittent claudication?

被引：0
作者：
不详
机构：
来源：
Drugs & Therapy Perspectives | 1999年 / 14卷 / 1期
关键词：
Human Immunodeficiency Virus Type; Clopidogrel; Peripheral Arterial Disease; Pentoxifylline; Cilostazol;
D O I：
10.2165/00042310-199914010-00001
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：1 / 5
页数：4
相关论文
共 50 条
[11]   Measuring treatment effects of cilostazol on clinical trial endpoints in patients with intermittent claudication [J].
Smith, JAM .
CLINICAL CARDIOLOGY, 2002, 25 (03) :91-94
[12]   Differential effects of cilostazol and pentoxifylline on vascular endothelial growth factor in patients with intermittent claudication [J].
Lee, TM ;
Su, SF ;
Tsai, CH ;
Lee, YT ;
Wang, SS .
CLINICAL SCIENCE, 2001, 101 (03) :305-311
[13]   Effect of Cilostazol Prescribed in a Pragmatic Treatment Program for Intermittent Claudication [J].
Lee, Constance ;
Nelson, Peter R. .
VASCULAR AND ENDOVASCULAR SURGERY, 2014, 48 (03) :224-229
[14]   Cilostazol treatment of claudication in diabetic patients [J].
Rendell, M ;
Cariski, AT ;
Hittel, N ;
Zhang, P .
CURRENT MEDICAL RESEARCH AND OPINION, 2002, 18 (08) :479-487
[15]   Effect of the novel antiplatelet agent cilostazol on plasma lipoproteins in patients with intermittent claudication [J].
Elam, MB ;
Heckman, J ;
Crouse, JR ;
Hunninghake, DB ;
Herd, JA ;
Davidson, M ;
Gordon, IL ;
Bortey, EB ;
Forbes, WP .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (12) :1942-1947
[16]   A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication [J].
Pande, Reena L. ;
Hiatt, William R. ;
Zhang, Peter ;
Hittel, Norbert ;
Creager, Mark A. .
VASCULAR MEDICINE, 2010, 15 (03) :181-188
[17]   The Limits of Evidence in Drug Approval and Availability: A Case Study of Cilostazol and Naftidrofuryl for the Treatment of Intermittent Claudication [J].
Hong, Haeyeon ;
Mackey, William C. .
CLINICAL THERAPEUTICS, 2014, 36 (08) :1290-1301
[18]   Differential lipogenic effects of cilostazol and pentoxifylline in patients with intermittent claudication: potential role for interleukin-6 [J].
Lee, TM ;
Su, SF ;
Hwang, JJ ;
Tseng, CD ;
Chen, MF ;
Lee, YT ;
Wang, SS .
ATHEROSCLEROSIS, 2001, 158 (02) :471-476
[19]   Intermittent claudication [J].
Alan T. Hirsch ;
Laura M. Reich .
Current Treatment Options in Cardiovascular Medicine, 2001, 3 (3) :167-180
[20]   Cilostazol is effective and safe option for the treatment of intermittent claudication Results of the NOCLAUD study [J].
Farkas Katalin ;
Jarai Zoltan ;
Kolossvary Endre .
ORVOSI HETILAP, 2017, 158 (04) :123-128
12345